Immune Reconstitution in Pediatric Patients Following Hematopoietic Cell Transplant for Non-malignant Disorders

Allogeneic hematopoietic cell transplant (HCT) is curative for pediatric patients with non-malignant hematopoietic disorders, including hemoglobinopathies, bone marrow failure syndromes, and primary immunodeficiencies. Early establishment of donor-derived innate and adaptive immunity following HCT i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatt, Sima T., Bednarski, Jeffrey J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461808/
https://www.ncbi.nlm.nih.gov/pubmed/33013851
http://dx.doi.org/10.3389/fimmu.2020.01988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461808/
https://www.ncbi.nlm.nih.gov/pubmed/33013851
http://dx.doi.org/10.3389/fimmu.2020.01988

Ejemplares similares